Lorazepam
Lorazepam Orion is a sedative and anxiolytic. The active substance is lorazepam, which belongs to a group of medicines called benzodiazepines.
Lorazepam Orion is used for the short-term treatment of severe, disabling anxiety in adults.
Before starting to take Lorazepam Orion, discuss with your doctor:
Consult your doctor if you are pregnant, planning to have a baby, or breastfeeding, or if you are of childbearing age (see section "Pregnancy and breastfeeding").
The use of benzodiazepines (even at therapeutic doses) may lead to physical and psychological dependence. To minimize the risk of dependence, use the lowest effective dose of Lorazepam Orion for the shortest possible period. Treatment should not last longer than 4 weeks. The need for continued treatment should be assessed if the treatment duration exceeds 4 weeks, and then regularly, preferably by the same doctor who started the treatment. The duration of treatment should not exceed a maximum of 2-3 months.
Lorazepam Orion should not be used in children and adolescents under 18 years of age.
Tell your doctor or pharmacist about all medicines you are taking now or have recently taken, as well as any medicines you plan to take.
Be particularly careful if you are taking the following medicines while taking Lorazepam Orion:
Taking these medicines together with lorazepam may increase or decrease the effect of lorazepam or increase the risk of side effects.
Taking Lorazepam Orion with opioids (strong painkillers, substitution therapy drugs, and some cough medicines) increases the risk of drowsiness, breathing difficulties (respiratory depression), coma, and can be life-threatening. Therefore, concurrent use should only be considered when other treatment options are not possible.
If your doctor has prescribed Lorazepam Orion with opioids, use the lowest effective dose, and the treatment duration should be as short as possible.
Tell your doctor about all opioid medicines you are taking, and strictly follow your doctor's dosage instructions. It may be helpful to inform friends or relatives about the possibility of the above-mentioned symptoms occurring in you.
If such symptoms occur, contact your doctor.
Tablets should be taken with a liquid. The medicine can be taken with or without food.
Alcohol:
Do not drink alcohol while taking this medicine, as alcohol may change or enhance the effect of Lorazepam Orion in an unpredictable way.
If you are pregnant, breastfeeding, think you may be pregnant, or plan to have a baby, ask your doctor for advice before taking this medicine.
Do not take Lorazepam Orion during pregnancy, especially in the first and last trimesters, as lorazepam may have a significant impact on the fetus.
If you become pregnant while taking Lorazepam Orion, inform your doctor immediately so that he can decide on a change of treatment.
Women of childbearing age must use effective contraception during treatment.
The active substance of Lorazepam Orion passes into breast milk and may cause drowsiness and feeding difficulties in the breastfed child. Your doctor will decide whether you should take this medicine while breastfeeding or stop breastfeeding, taking into account the expected benefits of treatment for the mother and the benefits of breastfeeding for the child.
Lorazepam Orion has a moderate to significant impact on the ability to drive and perform tasks that require precision, as it impairs the ability to react, causes sedation, drowsiness, and muscle relaxation. Additionally, Lorazepam Orion may cause side effects such as dizziness and vision disturbances. Do not drive or operate machinery while under the influence of lorazepam.
The medicine contains lactose monohydrate. If you have been diagnosed with intolerance to some sugars, contact your doctor before taking the medicine.
This medicine should always be taken exactly as your doctor has instructed. If you are unsure, ask your doctor or pharmacist.
The dosage and duration of treatment are determined individually for each patient.
Recommended dose:
The tablet can be divided into equal doses.
For doses that cannot be obtained using tablets of this strength, after consulting your doctor, it is recommended to use another available strength of Lorazepam Orion (1 mg).
The safety and efficacy of lorazepam in children and adolescents have not been established. Lorazepam Orion should not be used in children and adolescents under 18 years of age.
In case of overdose or accidental ingestion of the medicine by a child, contact your doctor or hospital for advice on the risk and the actions to be taken.
The following symptoms may occur: drowsiness, confusion, apathy, speech disorders, unsteady gait, depression, low blood pressure, decreased muscle strength, breathing difficulties, fainting with a weak pulse, paleness, blue discoloration of the lips and fingernails. In rare cases, coma has been observed. In very rare cases, Lorazepam Orion overdose can cause death.
Do not take a double dose to make up for a missed dose. Miss the missed dose and take the next planned dose.
Treatment may only be stopped or interrupted according to your doctor's instructions.
Your doctor may gradually decrease the dose of Lorazepam Orion, especially if high doses or long-term treatment is used.
If you suddenly stop taking Lorazepam Orion, you may experience withdrawal symptoms, such as headaches, muscle pain, anxiety, tension, restlessness, depression, insomnia, sweating, dizziness, confusion, and irritability. Additionally, after sudden discontinuation of the medicine, the symptoms that the medicine is intended to alleviate may worsen.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you experience any of the following symptoms, stop taking Lorazepam Orion and contact your doctor or go to the emergency department of your nearest hospital immediately:
severe allergic reaction. Symptoms of a severe allergic reaction include:
Very common (occurring in more than 1 in 10 patients):
Common (occurring in up to 1 in 10 patients):
Uncommon (occurring in up to 1 in 100 patients):
Rare (occurring in up to 1 in 1,000 patients):
Very rare (occurring in up to 1 in 10,000 patients):
Frequency not known (frequency cannot be estimated from the available data):
If you experience any side effects, including those not listed in this leaflet, please inform your doctor, pharmacist, or nurse. Side effects can be reported directly to the regulatory authority or to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181 C, 02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the blister and outer packaging after "Expiry date (EXP)". The expiry date refers to the last day of the month stated.
Do not store above 25°C. Store in the original packaging to protect from light and moisture.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Light yellow, round, flat tablets with beveled edges, approximately 8 mm x 3.1 mm in size, with the symbol "2.5" embossed on one side and a deep break line on the other side. The tablet can be divided into equal doses.
Packaging:
Soft aluminum/PE blister or OPA/Aluminum/PVC/Aluminum blister in a cardboard box.
Pack sizes:
Soft aluminum/PE blister: 10, 20, and 30 tablets.
OPA/Aluminum/PVC/Aluminum blister: 10, 20, 25, and 30 tablets
Not all pack sizes may be marketed.
Orion Corporation
Orionintie 1
FI-02200 Espoo
Finland
Orion Corporation Orion Pharma
Orionintie 1
FI-02200 Espoo
Finland
Orion Corporation Orion Pharma
Orionintie 1
FI-02200 Espoo
Finland
Orion Corporation Orion Pharma
Joensuunkatu 7
FI-24100 Salo
Finland
Orion Pharma Poland Sp. z o. o.
kontakt@orionpharma.info.pl
Date of last revision of the leaflet:02.09.2022
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.